PharmaSentinel Limited, a leading provider of AI-driven digital health solutions, is pleased to announce a significant license agreement with Pay10  for its flagship product, Medsii.com. This strategic partnership offers mutual benefits: it empowers PharmaSentinel to further develop and refine its innovative solutions, whilst also enabling Pay10 to strengthen its offerings in a distinct vertical.

Health Technology Insights: Luminopia’s Amblyopia Treatment Approved for Coverage by Anthem

Medsii.com is an advanced B2B platform that heavily leverages AI to provide a 360-degree verified view of scientific, clinical, regulatory, and competitive intelligence. Medsii enables PharmaSentinel to effectively penetrate and capitalise on the global £25 billion-per-year healthcare analytics market — a sector expanding at an impressive 20% CAGR.

“This agreement with Pay10 is a major milestone for PharmaSentinel,” said Fabrizio Ballantini, CEO of PharmaSentinel. “It validates our technology platform amid the growing demand for comprehensive intelligence solutions in the pharmaceutical and biotech sectors, reaffirming our commitment to innovation and informed decision-making. Although our platform is currently used by Life Sciences customers, its underlying technology is easily adaptable to other regulated industries such as law, financial services, and beyond”

Health Technology Insights: Centivo Strengthens Leadership Team with Appointment of Chief Financial Officer

The partnership will enable Pay10 to expand its intelligence services, offering enhanced insights and regulatory support to its global users. With this collaboration, both companies are set to drive innovation and improve data accessibility for stakeholders worldwide.

PharmaSentinel is a UK-based healthtech company that leverages AI to provide rapid, personalised, and timely regulatory and scientific medicines intelligence. Their platform is robust, scalable, secure, and GDPR compliant. PharmaSentinel’s technology helps pharmaceutical companies to discover faster medicines intelligence, save costs, and free up valuable resources to focus on higher-value activities. 

Health Technology Insights: Copper River Acquires Aspire Medical to Expand Healthcare Staffing

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – PR Newswire